Allergan Inc. (AGN) reported first quarter non-GAAP EPS of $0.98 Wednesday morning, compared to the consensus estimate of $0.96. The company expects to report second quarter non-GAAP EPS of $1.18 to $1.20 and between $4.70 and $4.76 for the full year 2013.
Allergan declined throughout the first half of Wednesday's session and closed down by 14.88 at $98.67 on the highest volume of the year. The stock plunged to nearly a 4-month low.
For comments and feedback: editorial@rttnews.com